A national programme championed by Academic Health Science Networks has announced £12.7m of awards in its latest competitions – including eight to companies in the Oxford AHSN region.
SBRI Healthcare, funded by NHS England, aims to develop innovative products and services towards better health experiences and outcomes. SBRI has eight categories – including diabetes (co-sponsored by the Oxford AHSN), mental health and patient safety. It covers three distinct phases – feasibility, prototype development and validation in NHS settings.
SBRI Healthcare Director Karen Livingstone said: “Through SBRI Healthcare we are seeing exciting new technologies and products that will bring a sea change in patient care. The programme is also building successful business in the life science sector – vital for UK growth.”
The latest awards winners include a number from companies based in the Oxford AHSN region. Among them are Milton Park-based Isansys Lifecare Ltd which was successful on two fronts:
- the development of a method for early detection of sepsis in the community to avoid hospital admission through primary care interventions for cancer patients undergoing chemotherapy.
- the development of a multiple vital sign patient data acquisition and analysis platform for rapid early detection of patient deterioration and avoidance of adverse events.
Other successful companies in our region were:
- Oncascan Ltd (Milton Park) – new colorectal cancer test identifying patients at earlier stage
- Oxford Medical Diagnostics Ltd (Yarnton) – breath ketone analysis for improved diabetes management
- P1vital Ltd (Wallingford) – assessment tool for managing treatment of depression
- ProReal Ltd (Oxford) – software development with applications in mental health
- Halliday James Ltd (Banbury) – sensors detecting changes in everyday activities indicating mood changes
- OBS Medical Ltd (Abingdon) – improving patient safety and outcomes through early detection of patient deterioration and instability
- Fuel 3D (Chinnor) – wound management system